Efficacy and Safety of Lens Extraction in Patients With Pseudoexfoliation Glaucoma

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

February 28, 2020

Study Completion Date

March 28, 2021

Conditions
Pseudoexfoliation GlaucomaIntraocular Pressure
Interventions
PROCEDURE

PHACOEMULSIFICATION

"Standard phacoemulsification with intraocular lens implant will be perform within 60 days after allocation. If IOP target is not achieve, patients will be treated as in medical treatment group"

DRUG

MEDICAL GLAUCOMA TREATMENT

The escalation of topical hypotensive medications will be carried out with the following sequence: 1. single topical medication; 2. double topical therapy; 3. triple topical therapy. Beginning, with the exception of individual contraindications, with prostaglandin analogs, followed by topical beta-blockers, carbonic anhydrase inhibitors and finally alpha-agonists.Target IOP will be used in both groups to inform the need of escalation of therapy; in patients with ocular hypertension the target IOP will be 21 mmHg. In patients with mild glaucoma target IOP will be 18 mmHg, and in patients with moderate glaucoma the target IOP will be 15 mmHg.

Trial Locations (1)

15405

Sara Pose-Bazarra, Ferrol

All Listed Sponsors
lead

Xerencia de Xestión Integrada de Ferrol

OTHER

NCT03494465 - Efficacy and Safety of Lens Extraction in Patients With Pseudoexfoliation Glaucoma | Biotech Hunter | Biotech Hunter